跳至主要内容
临床试验/NL-OMON50255
NL-OMON50255招募中不适用

Multi-Center Clinical Evaluation of the ATTUNE® Cementless Rotating Platform Total Knee Arthroplasty - 14022 ATTUNE(R) Cementless RP Clinical Performance Evaluation

DePuy Synthes Joint Reconstruction Inc0 个研究点目标入组 65 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • a) Subject is male or female and between the ages of 22 and 80 years at the
  • time of consent, inclusive.
  • b) Subject was diagnosed with NIDJD and in the opinion of the Investigator,
  • their condition is consistent with the indications detailed in the Instructions
  • c) Subject, in the opinion of the Investigator, is a suitable candidate for
  • cementless primary TKA using the devices described in this CIP with either
  • resurfaced or non-resurfaced patellae.
  • d) Subject that is willing to give voluntary, written informed consent to
  • participate in this clinical investigation and authorize the transfer of
  • his/her information to the Sponsor
  • e) Subject is currently not bedridden
  • f) Subject, in the opinion of the Investigator, is able to understand this
  • clinical investigation and is willing and able to perform all study procedures
  • and follow-up visits and co-operate with investigational procedures.
  • g) Subject is able to read, and comprehend the Informed Consent Document as
  • well as complete the required PROs in either English or one of the available
  • translations.

排除标准

  • a) The Subject is a woman who is pregnant or lactating.
  • b) Contralateral knee has already been enrolled in this study
  • c) Subject had a contralateral amputation.
  • d) Previous partial knee replacement (unicompartmental, bicompartamental or
  • patellofemoral joint replacement), patellectomy, high tibial osteotomy or
  • primary TKA in affected knee.
  • e) Subject is currently diagnosed with radicular pain from the spine that
  • radiates into the limb to receive TKA.
  • f) Subject has participated in a clinical investigation with an investigational
  • product (drug or device) in the last three (3) months.
  • g) Subject is currently involved in any personal injury litigation,
  • medical-legal or worker*s compensation claims.
  • h) Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in
  • the last 5 years) or has a psychological disorder that could affect their
  • ability to complete patient reported questionnaires or be compliant with
  • follow-up requirements.
  • i) Subject was diagnosed and is taking prescription medications to treat a
  • muscular disorder that limits mobility due to severe stiffness and pain such as
  • fibromyalgia or polymyalgia.
  • j) Subject has a significant neurological or musculoskeletal disorder(s) or
  • disease that may adversely affect gait or weight bearing (e.g., muscular
  • dystrophy, multiple sclerosis, Charcot disease).
  • k) Subject is suffering from inflammatory arthritis (e.g., rheumatoid
  • arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus
  • erythematosus, etc.).
  • l) Subject has a medical condition with less than five (5) years life
  • expectancy.
  • m) Uncontrolled gout

研究者

发起方
DePuy Synthes Joint Reconstruction Inc

相似试验